End of AIDS in sight — existing treatment prevents transmission of HIV

This could deal a huge blow to HIV.

A third patient might also be HIV-free

A cure is not here yet, but this certainly is promising.

Defeating HIV: second patient in history goes into sustained remission after stem cell transplant

Humanity strikes back: another win against HIV.

Promising new vaccine technology might finally end HIV-AIDS

Get lost, deadly virus.

HIV sexual transmission recorded live as the virus crosses the genital mucus membrane

It’s strangely beautiful, even though we’re talking about a dreaded pathogen.

A single injection protects monkey from HIV infections

It’s not exactly a vaccine, but it’s the next best thing.

Russia on the brink of HIV crisis as AIDS denial runs rampant through the country

The country might be on the verge of a health crisis.

What’s the difference between HIV and AIDS

You shouldn’t use the two interchangeably.

Five HIV patients are now virus-free thanks to a new vaccine therapy — but success rate is low

The new therapy gives the body new tools to weed out the HIV virus without any other drugs — one man has been HIV-free for 7 months.

Medication prevents HIV/AIDS has 92% success rate, but people don’t know about it yet

If taken daily, the pills can reduce the risk of HIV infection by up to 92 percent.

Revolutionary HIV vaccine to be tested on 600 people next year

We may be zooming in on a vaccine.

NIH isolates new antibody which neutralizes 98% of HIV strains in lab trials

We’re getting closer to a cure.

Drugs clear HIV from British patient’s system, offering hope for a cure

Five UK universities working together hope to bring an end to HIV.

Scientists stumble upon a vaccine which blocks HIV in monkeys – human trials planned

Scientists were surprised when they unexpectedly stumbled upon a relatively simple vaccine which blocks infection with SIV – the monkey equivalent of HIV – and stops the spread of the virus in already infected monkeys. How it works All efficient vaccines against a viral infection elicit virus-specific neutralizing antibodies and sometimes also cytotoxic T-lymphocytes (CTL) that prevent virus infection or

Study of HIV evolution shows the virus is adapting to human hosts

One of the most threatening modern pandemics, HIV/AIDS, has been thoroughly studied in the past few decades, with billions awarded to research seeking out a cure. Progress has been slow, but today doctors have a number of tools at their disposal to curve HIV development, spreading and ail patients, despite a cure has yet to be found (though hope exists

German scientists have managed to remove HIV from cells while leaving those cells alive

Using an enzyme to ‘cut out’ the virus, German researchers have managed to find remove HIV from cells, leaving the cells virtually unharmed. This has a boatload of work before it sees the light of day, but it’s the most promising HIV study I’ve read in quite a while. Killing HIV cells, mice, and a Petri dish The media has

No, people, 16% of Finnish population ISN’T immune to AIDS

As much as we here at ZME Science love promoting science, we really hate it when the media misinterprets research and spreads false information. This time, everybody seems to be picking up the idea that 16% of the Finnish population is genetically HIV resistant. Here, we’re gonna discuss that study and why this isn’t really true. C-C chemokine receptor type

Researchers observe antibodies evolve against HIV

For the first time, scientists have observed in a patient the evolution of an immune molecule that recognizes different HIV types and adapt accordingly. A neutralizing antibody, or NAb is an antibody which defends a cell from an antigen or infectious body by inhibiting or neutralizing any effect it has biologically. They’re your body’s elite force, who get sent in

First documented case of child cured of HIV

In what may very well become a historic day, Dr. Deborah Persaud of Johns Hopkins University described the first documented case of a child cured of HIV. Dr. Persaud, an amfAR grantee, detailed the case of a two-year-old child in Mississippi diagnosed with HIV at birth; the child was immediately put on antiretroviral therapy for 18 months. However, after this

HIV prevention drug approved by the FDA, decision criticized by AIDS support organization

The U.S. Food and Drug Administration recently gave its seal of approval for the introduction of  Truvada on the pharmaceutical market, a drug which allegedly can prevent HIV infection with an effectiveness rate as high as 75 percent when used in combination with safe sex practices. The Aids Healthcare Foundation (AHF), which is largest Aids support organisation in the world, however called the